Back to search
FDAFDA · Food and drugs·Recall number D-0628-2017

Adalat CC (nifedipine) Extended Release Tablets 30 mg, 100-count bottles, Rx only, Manufactured for Bayer Healthcare Bayer Healthcare Pharmaceuticals Inc. Whippany, NJ 07901 Manufactured in Germany, NDC 50419-701-05

Published April 12, 2017 · Recall initiated: March 7, 2017

Summary

FDA records drug Class III recall D-0628-2017, published April 12, 2017 and initiated March 7, 2017. Recalling firm: Alvogen, Inc; Status: Terminated; Reported quantity: N/A; Lot: Lot #: BXH1P21A, Exp. 11/2017. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Alvogen, Inc
Distributor
Nationwide
Lot
Lot #: BXH1P21A, Exp. 11/2017
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Adalat CC (nifedipine) Extended Release Tablets 30 mg, 100-count bottles, Rx only, Manufactured for Bayer Healthcare Bayer Healthcare Pharmaceuticals Inc. Whippany, NJ 07901 Manufactured in Germany, NDC 50419-701-05 recalled?

Yes. FDA published recall D-0628-2017 on April 12, 2017. Reported hazard: Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib

What should I do if I have this product?

Voluntary: Firm initiated · Letter